Esperion Therapeutics (ESPR) Property, Plant & Equipment (Net) Growth (1y) (2013 - 2026)
Esperion Therapeutics (ESPR) Property, Plant & Equipment (Net) Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -13.67% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 8.08% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.30% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -4.01% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 4.48% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 33.24% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -5.70% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -12.84% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 114.41% |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | 36.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.40% |
| Dec 31, 2025 | 33.07% |
| Sep 30, 2025 | -37.72% |
| Jun 30, 2025 | -34.53% |
| Mar 31, 2025 | -14.93% |
| Sep 30, 2024 | 4,583.33% |
| Jun 30, 2024 | 859.38% |
| Mar 31, 2024 | 222.89% |
| Sep 30, 2023 | -97.66% |
| Jun 30, 2023 | -91.14% |
| Mar 31, 2023 | -83.76% |
| Dec 31, 2022 | -75.30% |
| Sep 30, 2022 | -68.67% |
| Jun 30, 2022 | -62.78% |
| Mar 31, 2022 | -54.50% |
| Dec 31, 2021 | -47.96% |
| Sep 30, 2021 | -41.97% |
| Jun 30, 2021 | -35.85% |
| Mar 31, 2021 | -22.39% |
| Dec 31, 2020 | 11.44% |